Strategies for Prevention and Treatment of Trichomonas vaginalis Infections

被引：77

作者：

Bouchemal, Kawthar ^{[1
,2
]}

Bories, Christian ^{[3
]}

Loiseau, Philippe M. ^{[3
]}

机构：

[1] Univ Paris Saclay, Inst Galien Paris Sud, Fac Pharm, Chatenay Malabry, France

[2] Univ Paris Saclay, Univ Paris Sud, Inst Univ France, UMR 8612,CNRS,Fac Pharm, Chatenay Malabry, France

[3] Univ Paris Saclay, Univ Paris Sud, Biomol Concept Isolement Synth BioCIS Chimiothera, UMR 8076,CNRS,Fac Pharm, Chatenay Malabry, France

来源：

CLINICAL MICROBIOLOGY REVIEWS | 2017年 / 30卷 / 03期

关键词：

Trichomonas vaginalis; HUMAN-PAPILLOMAVIRUS INFECTION; SEXUALLY-TRANSMITTED-DISEASES; RISK HUMAN-PAPILLOMAVIRUS; MALE CIRCUMCISION; POVIDONE-IODINE; ORAL METRONIDAZOLE; DRUG-DELIVERY; POLY(ISOBUTYLCYANOACRYLATE) NANOPARTICLES; BOVINE TRICHOMONIASIS; NEISSERIA-GONORRHOEAE;

D O I：

10.1128/CMR.00109-16

中图分类号：

Q93 [微生物学];

学科分类号：

071005 ; 100705 ;

摘要：

The last estimated annual incidence of Trichomonas vaginalis worldwide exceeds that of chlamydia and gonorrhea combined. This critical review updates the state of the art on advances in T. vaginalis diagnostics and strategies for treatment and prevention of trichomoniasis. In particular, new data on treatment outcomes for topical administration of formulations are reviewed and discussed.

引用

页码：811 / 825

页数：15

共 137 条

[1] Recalcitrant Trichomonas Vaginalis Infections Successfully Treated With Vaginal Acidification [J].

Aggarwal, Anjali ;

Shier, R. Michael .

JOURNAL OF OBSTETRICS AND GYNAECOLOGY CANADA, 2008, 30 (01) :55-58

[2] Formulation of mucoadhesive vaginal hydrogels insensitive to dilution with vaginal fluids [J].

Aka-Any-Grah, Armelle ;

Bouchemal, Kawthar ;

Koffi, Armand ;

Agnely, Florence ;

Zhang, Min ;

Djabourov, Madeleine ;

Ponchel, Gilles .

EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS, 2010, 76 (02) :296-303

[3]

[Anonymous], DRUG DELIVERY DEV AN

[4]

Anorlu R I, 2001, Niger Postgrad Med J, V8, P183

[5] Randomized, controlled intervention trial of male circumcision for reduction of HIV infection risk: The ANRS 1265 trial [J].

Auvert, B ;

Taljaard, D ;

Lagarde, E ;

Sobngwi-Tambekou, J ;

Sitta, M ;

Puren, A .

PLOS MEDICINE, 2005, 2 (11) :1112-1122

[6] Characterization of a Hormone-Responsive Organotypic Human Vaginal Tissue Model: Morphologic and Immunologic Effects [J].

Ayehunie, Seyoum ;

Islam, Ayesha ;

Cannon, Chris ;

Landry, Timothy ;

Pudney, Jeffrey ;

Klausner, Mitchell ;

Anderson, Deborah J. .

REPRODUCTIVE SCIENCES, 2015, 22 (08) :980-990

[7] Trichomonas vaginalis Genital Infections: Progress and Challenges [J].

Bachmann, Laura H. ;

Hobbs, Marcia M. ;

Sena, Arlene C. ;

Sobel, Jack D. ;

Schwebke, Jane R. ;

Krieger, John N. ;

McClelland, R. Scott ;

Workowski, Kimberly A. .

CLINICAL INFECTIOUS DISEASES, 2011, 53 :S160-S172

[8] A preliminary evaluation of a new GeneXpert (Gx) molecular point-of-care test for the detection of Trichomonas vaginalis [J].

Badman, S. G. ;

Causer, L. M. ;

Guy, R. ;

Tabrizi, S. N. ;

Francis, F. ;

Donovan, B. ;

Whiley, D. .

SEXUALLY TRANSMITTED INFECTIONS, 2016, 92 (05) :350-U117

[9] Male circumcision for HIV prevention in young men in Kisumu, Kenya: a randomised controlled trial [J].

Bailey, Robert C. ;

Moses, Stephen ;

Parker, Corette B. ;

Agot, Kawango ;

Maclean, Ian ;

Krieger, John N. ;

Williams, Carolyn F. M. ;

Campbell, Richard T. ;

Ninya-Achola, Jeckoniah O. .

LANCET, 2007, 369 (9562) :643-656

[10]

Benchimol M., 2015, Human Emerging and Re-emerging Infections, P423

← 1 2 3 4 5 6 7 8 9 10 →